Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05612880 · ClinicalTrials.gov registry record
Physical Function During ARSI Treatment
A clinical trial, sponsored by UNC Lineberger Comprehensive Cancer Center.
- Completed
- Registry status
- 24
- Enrollment target
NCT05612880 is a clinical trial that has completed, run by UNC Lineberger Comprehensive Cancer Center. The registered enrollment target is 24 participants.
The verdict
NCT05612880 has completed, sponsored by UNC Lineberger Comprehensive Cancer Center.
- COMPLETED
- Registry status
- 24 participants
- Enrollment target
Study Summary
This single arm observational pilot study aims to determine the longitudinal effects of androgen receptor signaling inhibitors (ARSI) in men with advanced prostate cancer. The primary outcome for this trial is physical function, which will be evaluated at baseline, 12 and 24 weeks. Secondary outcomes including body composition, muscle function, balance, arterial stiffness and patient reported outcomes.
Interventions
- DRUG androgen receptor signaling inhibitors
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2022-10-13 |
| Est. Completion | 2024-11-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05612880
The ClinicalTrials.gov registry entry for NCT05612880 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is UNC Lineberger Comprehensive Cancer Center, which has 366 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which androgen receptor signaling inhibitors is the first listed.
NCT05612880 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05612880 about?
NCT05612880 is a clinical study titled "Physical Function During ARSI Treatment". This single arm observational pilot study aims to determine the longitudinal effects of androgen receptor signaling inhibitors (ARSI) in men with advanced prostate cancer. The primary outcome for this trial is physical function, which will be evaluated at baseline, 12 and 24 weeks. Secondary outcome...
What is the current status of trial NCT05612880?
This trial is currently completed. The enrollment target is 24 participants. The study started on 2022-10-13. Estimated completion is 2024-11-06.
What interventions are being tested in trial NCT05612880?
The interventions under investigation include: androgen receptor signaling inhibitors (DRUG).
Who is sponsoring clinical trial NCT05612880?
This trial is sponsored by UNC Lineberger Comprehensive Cancer Center, which has 366 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.